Inaktiver Wert

BioMimetic Therapeutics, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

BioMimetic Therapeutics, Inc. : Initiates Enrollment in Augment? Chronic Tendinopathy Clinical Trial	03.01.13
BioMimetic Therapeutics, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of BioMimetic Therapeutics, Inc.	20.11.12
BioMimetic Therapeutics, Inc. : BioMimetic Therapeutics Investor Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to Wright Medical Group	20.11.12
BioMimetic Therapeutics, Inc. : Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses	19.11.12
BioMimetic Therapeutics, Inc. : Reports Third Quarter 2012 Financial Results	05.11.12

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	+15,82 %	121 Mrd.
REGENERON PHARMACEUTICALS, INC.	+20,35 %	113 Mrd.
ARGENX SE	+17,47 %	26,02 Mrd.
BIONTECH SE	-25,31 %	19,39 Mrd.
GENMAB A/S	-19,51 %	15,91 Mrd.
BEIGENE, LTD.	-19,67 %	15,09 Mrd.
WUXI APPTEC CO., LTD.	-46,87 %	15,06 Mrd.
SAREPTA THERAPEUTICS, INC.	+62,55 %	14,93 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+6,34 %	13,85 Mrd.